Back to Agenda
IVD Regulation and the Upcoming Changes in Regulatory Landscape
Session Chair(s)
Claudia Dollins, PHD, RAC
Vice President, Precision Medicines, Global Regulatory Affairs, GlaxoSmithKline, United States
IVD Regulation and the Upcoming Changes in Regulatory Landscape
Speaker(s)
Anna Hallersten, MSC
Head Regulatory Policy Europe, Roche Diagnostics, Switzerland
Panel Discussion
Sue Spencer
Head of Global Medical Devices, UL, United Kingdom
Panel Discussion
Stephen Lee
Senior Regulatory Policy Manager, Medicines & Healthcare Products Regulatory Agency (MHRA), United Kingdom
Panel Discussion
Have an account?